A critical look at the frog secretion ritual gaining traction in wellness circles — and the medical evidence that should give you serious pause.
What Is Kambo?
Kambo is positioned by its advocates as one of the most potent traditional medicines available — a powerful "detox" that purges the body and mind of physical and spiritual toxins. The secretion comes from Phyllomedusa bicolor, commonly called the giant monkey frog or giant leaf frog, a tree frog widely distributed across South American countries whose skin secretion is rich in bioactive peptides and has been used in indigenous rituals for centuries.
In the ritual, the secretion is applied directly to small burns made on the skin. What follows is immediate and violent: within minutes, the body purges. Advocates call it transformation. Medicine calls it a pharmacological crisis.
Why People Are Drawn to It
Compared to Ayahuasca — which involves multi-hour ceremonies, intense psychedelic visions, and a demanding psychological journey — Kambo offers a shorter timeline with no psychedelic component. There are no trippy visuals, no dream-like states, no prolonged altered consciousness. For people who want the prestige of a "healing ceremony" without the psychological exposure of a full plant medicine experience, Kambo looks appealing.
That is roughly where the advantages end.
The Chemistry: What's Actually in Kambo
A variety of potent bioactive peptides have been identified in the frog's secretion, including phyllocaerulein, phyllokinin, phyllomedusin, sauvagine, ceruletide, adenoregulin, and the potent opioids dermorphin and deltorphin.
These peptides interact with a diverse range of neurotransmitter and hormone receptor systems — specifically engaging cholecystokinin (CCK) receptors, neurokinin-1 (NK1) receptors, bradykinin B2 receptors, corticotropin-releasing factor (CRF) receptors, and opioid receptors (mu and delta subtypes) — influencing gastrointestinal, cardiovascular, endocrine, and neurological pathways.
In plain terms: Kambo hits nearly every major biological system simultaneously. Within a few minutes after application, nausea, vomiting, facial edema, palpitations, and hypotension can occur.
Proponents frame these as the "purge" — toxins leaving the body. Pharmacologists frame them as an acute multi-system stress response. Research has proposed that Kambo's effects involve potent pharmacological action of various bioactive peptides on the autonomic and somatic nervous system, combined with psychological effects of the ritual framework and symbolic aspects of the cleansing experience. None of this constitutes medical treatment.
Over six decades of peptide research have given rise to more than 70 patents lodged primarily in the United States — but patents are not clinical approvals. They reflect commercial interest in isolating specific compounds, not evidence that the whole-secretion ritual is safe or effective.
The Legal Gray Zone That Makes This More Dangerous
Unlike Ayahuasca — which contains DMT, a Schedule I controlled substance in the US and illegal across most of Europe — Kambo operates in a legal vacuum that creates serious public safety problems.
Kambo is generally legal in most countries worldwide, unscheduled and unregulated in many regions. In the United States, it is completely unregulated — subject to similar laws as dietary supplements or other unapproved interventions, with no grounds for legal prosecution for its use, possession, or distribution.
In the UK, Kambo is not classified as a regulated medicine, and there is no specific licensing mechanism in place. This means that anyone — with any level of training, any dosing protocol, any screening process — can administer Kambo ceremonies. The absence of regulation does not signal safety. It signals an absence of oversight.
That gap in Kambo-specific rules doesn't mean no law applies at all — after Kristian Trend's death (below), police arrested a man on suspicion of administering poison, a general criminal offence that predates Kambo by more than a century. But a criminal investigation after a death is a poor substitute for licensing, screening, or oversight before someone is burned and dosed.
The US Embassy in Lima issued a formal health alert in January 2025, warning American citizens not to ingest Kambo or Ayahuasca in Peru, noting that in 2024, several US citizens died or experienced severe illness following use of these substances.
The one jurisdiction that moved decisively after a fatality was Australia: following a death in 2019, the Australian government's Therapeutic Goods Administration banned Kambo and categorized it as a Schedule 10 substance — substances considered of such danger to health as to warrant prohibition of sale, supply, and use.
The Deaths and Hospitalizations: What We Know
In April 2026, Kristian Trend, a 40-year-old wellness coach and cancer survivor from Leicester, collapsed during a Kambo "cleansing ceremony" at a private flat in the city's Clarendon Park area and died in hospital shortly after. Leicestershire Police arrested a 41-year-old man on suspicion of administering poison; he was released on bail while the investigation continued. As of the most recent reporting, toxicology results and the coroner's inquest were still pending — a confirmed cause of death has not been made public — but the case is widely reported as the first known Kambo-linked death in the UK. Trend's mother, who said her son turned to spirituality and alternative healing after surviving Burkitt lymphoma, has called for the substance to be banned; MPs from multiple parties have reportedly echoed that call.
Documented harms from Kambo have included hepatitis, psychosis, prolonged vomiting, hyponatremia (low blood sodium), seizure, rupture of the oesophagus, and cardiac arrest.
There have been multiple high-profile deaths linked to Kambo in Western ceremonies, and probably more that have not been reported — many ceremonies operate far outside hospital systems and medical oversight, making accurate figures impossible to obtain.
The most alarming recent medical case study, published in May 2025 in Cureus, documents the first formally reported case of brain death attributed to Kambo toxicity: a 35-year-old woman developed headache, emesis, and a unilateral fixed and dilated pupil within hours of a Kambo ritual. Imaging revealed diffuse cerebral edema and loss of intracranial blood flow. Laboratory workup showed severe hyponatremia — likely due to excessive water intake, peptide-induced emesis with sodium loss, and suspected syndrome of inappropriate antidiuretic hormone secretion (SIADH). Despite aggressive medical management, the patient progressed to brain death.
The mechanism matters: the ritual's unique combination of cutaneous toxin delivery, extreme emesis, and the common practice of ritualistic overhydration creates a perfect storm for acute symptomatic hyponatremia and cerebral herniation. Participants are often instructed to drink large quantities of water before and during ceremonies, which — combined with the peptides disrupting antidiuretic hormone regulation — can send sodium levels into a lethal range.
A 2025 systematic review on Kambo and sudden death concluded that while only a limited number of fatalities have been formally documented, those cases emphasise the need to seriously consider the potential for catastrophic outcomes from unregulated administration.
No Clinical Trials. That's the Point.
Unlike psilocybin — which is the subject of large-scale clinical trials at Johns Hopkins, NYU, and Imperial College London — and unlike 5-MeO-DMT (Toad) research being conducted at multiple institutions, Kambo has generated virtually no rigorous clinical science.
Research into the pharmaceutical benefit of the peptides from Kambo started in the early 1960s, but did not result in the introduction of new therapeutic principles in the clinic — most probably due to the absence of patent protection.
That is a telling sentence. Sixty years of peptide research produced no approved treatments and no clinical trials — not because the research was suppressed, but because the science didn't support it. The absence of clinical trials for Kambo, in an era when psychedelic medicine research is flourishing, is not an accident. It is a signal.
The Reddit Problem
Search Reddit for Kambo and you will find expansive, warm community threads — integration stories, ceremony recommendations, facilitator reviews, and enthusiastic accounts of profound transformation. These communities are populated by people genuinely seeking healing, and their experiences are real to them.
But personal accounts are not evidence. They are not screened for confounding variables, they do not track adverse events, and they do not account for survivorship bias — the people who had dangerous reactions are not posting in Kambo communities. They are in hospitals, or they are silent.
This is particularly concerning when Kambo is discussed adjacent to Ayahuasca, Toad, or psilocybin — medicines that do have growing bodies of clinical research. The association lends Kambo a credibility by proximity that it has not earned.
Kambo rituals are unregulated and increasingly practiced in Western countries despite a lack of medical oversight. The growing social media presence of Kambo practice does not change that fact.
The Bottom Line
Kambo is not the accessible, no-trip alternative to plant medicine that it is marketed as. It is a pharmacologically potent multi-system intervention with no regulatory oversight, no clinical trial evidence, a documented capacity to kill, and a legal status that enables it to be administered by anyone, anywhere, in any dose.
If you are on a healing journey — and the fact that you are reading this suggests you are — that journey deserves the rigor of evidence, the protection of qualified practitioners, and the safeguards of medical supervision. Kambo currently offers none of these.
Public awareness, clinician education, and the development of clear safety protocols are critical as the use of this unregulated practice continues to expand. Until the science catches up — if it ever does — the most honest thing we can say about Kambo is this: we do not know enough to endorse it, and what we do know gives significant cause for caution.
This article is for informational purposes only and does not constitute medical advice. If you or someone you know experiences adverse effects following a Kambo ceremony, seek emergency medical care immediately.
Sources
- Tran, C. Q., Houston, R., Marino, M. A., Schiraldi, M., & Miulli, D. E. (2025). Shamanic Kambo Frog Hyponatremic Toxicity Leading to Brain Death: A Case Report. Cureus, 17(5), e83963.
- Sacco et al. (2025). Kambo Administration and Its Association With Sudden Death: Clinical and Forensic Perspectives From a Systematic Review. Cureus.
- US Embassy Lima health alert (January 2025) on Kambo and Ayahuasca use in Peru.
- Australian Therapeutic Goods Administration Schedule 10 classification of Kambo, following a 2019 death.
- LBC and GB News reporting (May 2026) on the death of Kristian Trend, Leicester, and subsequent police and coronial proceedings.